€100,000 investment opportunity for central nervous system research

News

Author: Parkinson's Life editorsPublished: 6 June 2018

Prep: Cook: Serves:

Zcube, a research venture of Italian pharmaceutical company Zambon, has invited researchers, scientists and aspiring entrepreneurs to apply for its third international Open Accelerator programme.

The programme – which runs for 12 weeks at the Openzone campus in Milan, Italy – will have a specific focus on the therapeutic areas of the central nervous system and the respiratory system, including rare diseases in these two areas. Upon completing the accelerator, participants will have the chance to win seed investment of up to €100,000 to develop their projects in collaboration with Zambon.

Elena Zambon, president of Zambon, said: “Open Accelerator is a fundamental ‘school’ teaching young researchers how to communicate with the business world and venture capitalists and to take their ideas out of the laboratories and let them become effective opportunities to improve patients’ lives.”

Submissions for the accelerator programme are open until 30 June 2018.

To apply for the Open Accelerator programme click here.

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Michael J Fox Foundation Tour de Fox Series 2016

Registration for the Team Fox summer 2016 cycle series now open

Perspectives

“Today, my life is worth living again”

How DBS treatment gave Pete Vanderburg a new lease of life

Health & Fitness

Easier to swallow – dysphagia in Parkinson’s

Practical advice on making oral medication easier to swallow

Parkinson’s Europe co-founder Lizzie Graham wins World Parkinson Coalition award

Parkinson’s Europe co-founder Lizzie Graham has won a World Parkinson Coalition (WPC) award for her contribution to the Parkinson’s community. Lizzie is one of four people set to receive the Robin Elliott Award – which is given out every three years to individuals whose efforts best embody the goals and ethos of the WPC. She will be presented with the award in a ceremony at the World Parkinson’s Congress, which will be held in Barcelona later this year. Commenting on the news of Lizzie’s award, Parkinson’s Europe President, Veronica Clark, said: “Lizzie is Lizzie, and we love her for who she is and what she has done for us all – for people with Parkinson’s past and present and, I’m sure, future.” Lizzie co-founded the European Parkinson’s Disease Association (renamed Parkinson’s Europe last year) in 1992. She has since held several roles within the organisation – including secretary general and…

Study explores predictors of cognitive impairment in Parkinson’s disease

Cognitive impairment can affect some people with Parkinson’s – and may greatly impact their quality of life. Now, researchers in China have examined the possible risk factors for cognitive impairment in those with the condition. The study analysed data from 409 people with Parkinson’s within two years of their involvement in the Parkinson’s Progression Markers Initiative (PPMI) – an international study that follows people with and without the condition over time. The participants, who were newly diagnosed and experiencing normal cognitive function at the start of the research, were studied for at least five years. Published in ‘Frontiers in Aging Neuroscience’, the results indicate that older age at onset, high blood pressure and worse baseline motor symptoms may be among factors that could contribute to an increased risk of developing cognitive impairment. The researchers cautioned that “a larger sample and much more comprehensive assessment, and prolonged follow-up, will be required”.

Could frailty be a potential risk factor for Parkinson’s disease?

Frailty can refer to a reduction in physical function, and its attributes – including a slow walking speed and weak grip – are commonly experienced by people with Parkinson’s. Until now, there has been limited insight into the link between frailty and the risk of developing the condition over time. This is what led researchers at the Huazhong University of Science and Technology in China to analyse data from a large UK study, which was gathered over a 12-year period. Published in JAMA Neurology, the analysis found that frailty may be linked to an 87% higher risk of developing the condition. Commenting on the results, the researchers said: “These findings indicate that physical frailty is a potential risk factor for [Parkinson’s], and the assessment and management of frailty might have clinical significance in the at-risk population.”

All fields required